Adc Therapeutics Sa · NYSE:ADCT
Coughlin Timothy received 45,000 Adc Therapeutics Sa shares as an award (Form 4)
Traded Jun 1 to Jun 3, 2026 · Filed Jun 3, 2026
From Jun 1 to Jun 3, 2026, Coughlin Timothy (Director) received 45,000 Adc Therapeutics Sa shares as an award, leaving 72,400 shares. Filed Jun 3, 2026 (Form 4).
- Awarded
- 45,000 shares
- Holding after
- 72,400 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Shares | Award | 45,000 | 85,000 | Direct | |
| Jun 3, 2026 | Common Shares | Shares withheld for tax | 12,600 | US$3.08 | 72,400 | Direct |